Article Text

Download PDFPDF
Letter
Challenges in chronic paediatric disease during the COVID-19 pandemic: diagnosis and management of inflammatory bowel disease in children
  1. James J Ashton1,2,
  2. Akshay Batra2,
  3. Tracy A F Coelho2,
  4. Nadeem A Afzal2,
  5. R Mark Beattie2
  1. 1 Human Genetics and Genomic Medicine, University of Southampton, Southampton, UK
  2. 2 Department of Paediatric Gastroenterology, Southampton Children's Hospital, Southampton, UK
  1. Correspondence to Professor R Mark Beattie, Department of Paediatric Gastroenterology, Southampton Children's Hospital, Southampton SO16 6YD, UK; mark.beattie{at}uhs.nhs.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Many paediatric healthcare professionals are increasingly concerned about the long-term secondary impact of the COVID-19 pandemic on the care of children and young people (CYP) with chronic conditions. Those of us working in paediatric gastroenterology now lack the ability to provide the same level of diagnostic care and ongoing management to our patients, particularly the large number with inflammatory bowel disease (IBD). With all elective endoscopy cancelled, difficulty in obtaining day-case infusions and telemedicine becoming the norm, many professionals are justifiably uncomfortable. There is little known about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on those CYP with IBD, or on patients with systemic immunosuppression, although the small amount of data derived thus far indicates mild disease in …

View Full Text

Linked Articles

  • Atoms
    Nick Brown